CN105658250A - 包含颗粒状脱细胞组织的混合凝胶 - Google Patents
包含颗粒状脱细胞组织的混合凝胶 Download PDFInfo
- Publication number
- CN105658250A CN105658250A CN201480038295.XA CN201480038295A CN105658250A CN 105658250 A CN105658250 A CN 105658250A CN 201480038295 A CN201480038295 A CN 201480038295A CN 105658250 A CN105658250 A CN 105658250A
- Authority
- CN
- China
- Prior art keywords
- cell
- tissue
- biological tissue
- animal
- test kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims abstract description 114
- 241001465754 Metazoa Species 0.000 claims abstract description 108
- 108090000190 Thrombin Proteins 0.000 claims abstract description 43
- 229960004072 thrombin Drugs 0.000 claims abstract description 43
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 28
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 28
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 25
- 201000010099 disease Diseases 0.000 claims abstract description 20
- 210000000130 stem cell Anatomy 0.000 claims abstract description 18
- 238000004113 cell culture Methods 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims description 213
- 210000002216 heart Anatomy 0.000 claims description 84
- 238000012360 testing method Methods 0.000 claims description 65
- 238000004519 manufacturing process Methods 0.000 claims description 37
- 238000002560 therapeutic procedure Methods 0.000 claims description 37
- 210000003491 skin Anatomy 0.000 claims description 35
- 230000017423 tissue regeneration Effects 0.000 claims description 35
- 210000004185 liver Anatomy 0.000 claims description 33
- 238000012545 processing Methods 0.000 claims description 33
- 238000009931 pascalization Methods 0.000 claims description 32
- 230000001537 neural effect Effects 0.000 claims description 27
- 210000004556 brain Anatomy 0.000 claims description 26
- 238000004108 freeze drying Methods 0.000 claims description 26
- 210000003734 kidney Anatomy 0.000 claims description 25
- 239000002243 precursor Substances 0.000 claims description 25
- 210000000278 spinal cord Anatomy 0.000 claims description 24
- 210000004072 lung Anatomy 0.000 claims description 23
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 21
- 208000010125 myocardial infarction Diseases 0.000 claims description 18
- 238000002054 transplantation Methods 0.000 claims description 18
- 210000005036 nerve Anatomy 0.000 claims description 12
- 208000001034 Frostbite Diseases 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000006143 cell culture medium Substances 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 8
- 208000028389 Nerve injury Diseases 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 230000008764 nerve damage Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 37
- 230000004069 differentiation Effects 0.000 abstract description 11
- 238000000227 grinding Methods 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 333
- 239000000499 gel Substances 0.000 description 125
- 241000283973 Oryctolagus cuniculus Species 0.000 description 42
- 230000008569 process Effects 0.000 description 28
- 241000700159 Rattus Species 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
- 238000004140 cleaning Methods 0.000 description 19
- 241000282898 Sus scrofa Species 0.000 description 18
- 239000012530 fluid Substances 0.000 description 18
- 239000000843 powder Substances 0.000 description 14
- 210000003932 urinary bladder Anatomy 0.000 description 12
- 210000004204 blood vessel Anatomy 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 241000283073 Equus caballus Species 0.000 description 9
- 239000004744 fabric Substances 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 241000271566 Aves Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000012620 biological material Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 8
- 229920000573 polyethylene Polymers 0.000 description 8
- 210000001625 seminal vesicle Anatomy 0.000 description 8
- 201000010653 vesiculitis Diseases 0.000 description 8
- 208000009084 Cold Injury Diseases 0.000 description 7
- 101710163270 Nuclease Proteins 0.000 description 7
- 241000700157 Rattus norvegicus Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000002595 cold damage Effects 0.000 description 7
- 108010073385 Fibrin Proteins 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- 206010062575 Muscle contracture Diseases 0.000 description 6
- 208000006111 contracture Diseases 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 230000008595 infiltration Effects 0.000 description 6
- 238000001764 infiltration Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 230000024245 cell differentiation Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000004165 myocardium Anatomy 0.000 description 5
- 210000002241 neurite Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 4
- 241000272525 Anas platyrhynchos Species 0.000 description 4
- 241000272814 Anser sp. Species 0.000 description 4
- 241000726096 Aratinga Species 0.000 description 4
- 241001416153 Bos grunniens Species 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000282836 Camelus dromedarius Species 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 241000282994 Cervidae Species 0.000 description 4
- 241000699800 Cricetinae Species 0.000 description 4
- 241000283074 Equus asinus Species 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241000922569 Hypodematium crenatum Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000272458 Numididae Species 0.000 description 4
- 241001482564 Nyctereutes procyonoides Species 0.000 description 4
- 241001494479 Pecora Species 0.000 description 4
- 241000286209 Phasianidae Species 0.000 description 4
- 241001404174 Psittacula alexandri fasciata Species 0.000 description 4
- 241000555736 Sciurus vulgaris Species 0.000 description 4
- 241000271567 Struthioniformes Species 0.000 description 4
- 102000004243 Tubulin Human genes 0.000 description 4
- 108090000704 Tubulin Proteins 0.000 description 4
- 241001416177 Vicugna pacos Species 0.000 description 4
- 241000282485 Vulpes vulpes Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- 238000010009 beating Methods 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000001112 cardioblast Anatomy 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000010247 heart contraction Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000001672 ovary Anatomy 0.000 description 4
- 210000003101 oviduct Anatomy 0.000 description 4
- 210000002741 palatine tonsil Anatomy 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 229960001412 pentobarbital Drugs 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 210000002105 tongue Anatomy 0.000 description 4
- 210000000626 ureter Anatomy 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 206010015548 Euthanasia Diseases 0.000 description 3
- 229920000153 Povidone-iodine Polymers 0.000 description 3
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 238000011532 immunohistochemical staining Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 229960001621 povidone-iodine Drugs 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- 208000021970 Abdominal wall defect Diseases 0.000 description 1
- 239000012110 Alexa Fluor 594 Substances 0.000 description 1
- 108010023728 Alloderm Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 238000012425 Freezing-thawing process Methods 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- 102000004531 Selenoprotein P Human genes 0.000 description 1
- 108010042443 Selenoprotein P Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000007348 cell dedifferentiation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 206010023683 lagophthalmos Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000009753 muscle formation Effects 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/56—Fibrin; Thrombin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
Abstract
Description
Claims (49)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013097399 | 2013-05-07 | ||
JP2013-097399 | 2013-05-07 | ||
PCT/JP2014/062544 WO2014181886A1 (ja) | 2013-05-07 | 2014-05-02 | 粒子状脱細胞化組織を含むハイブリッドゲル |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105658250A true CN105658250A (zh) | 2016-06-08 |
CN105658250B CN105658250B (zh) | 2019-02-26 |
Family
ID=51867357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480038295.XA Active CN105658250B (zh) | 2013-05-07 | 2014-05-02 | 包含颗粒状脱细胞组织的混合凝胶 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20160051731A1 (zh) |
EP (1) | EP2995326B1 (zh) |
JP (1) | JP6553507B2 (zh) |
KR (1) | KR102339700B1 (zh) |
CN (1) | CN105658250B (zh) |
CA (1) | CA2911592C (zh) |
HK (1) | HK1222137A1 (zh) |
WO (1) | WO2014181886A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108295311A (zh) * | 2018-03-07 | 2018-07-20 | 南京市第医院 | 一种温敏型肾脏细胞外基质水凝胶的制备方法 |
WO2019100454A1 (zh) * | 2017-11-27 | 2019-05-31 | 大连理工大学 | 一种三维肿瘤模型脱细胞多孔支架、构建方法及其应用 |
CN109890121A (zh) * | 2019-04-01 | 2019-06-14 | 西安交通大学 | 一种等离子体发生装置及等离子体凝胶制备方法 |
CN110038163A (zh) * | 2019-04-16 | 2019-07-23 | 上海大学 | 一种用于修复腹壁缺损的水凝胶复合生物补片制备方法 |
CN110638684A (zh) * | 2019-09-02 | 2020-01-03 | 深圳兰度生物材料有限公司 | 一种可注射的胶原组合物及制备方法 |
CN114099782A (zh) * | 2021-12-02 | 2022-03-01 | 龚玉兰 | 一种可重构的子宫衍生材料的制备方法与应用 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6666898B2 (ja) * | 2015-02-27 | 2020-03-18 | 株式会社Adeka | 脱細胞化組織 |
CN104984398B (zh) * | 2015-07-01 | 2018-03-30 | 上海交通大学医学院附属第九人民医院 | 一种注射型组织工程骨凝胶载体的制备方法及应用 |
US10881761B2 (en) * | 2015-08-11 | 2021-01-05 | Acro Biomedical Company. Ltd. | Preparation of high purity collagen particles and uses thereof |
US20180273904A1 (en) * | 2015-10-02 | 2018-09-27 | Wake Forest University Health Sciences | Spontaneously beating cardiac organoid constructs and integrated body-on-chip apparatus containing the same |
CN106913907B (zh) * | 2015-12-25 | 2022-04-05 | 北京瑞健高科生物科技有限公司 | 一种具有结构记忆特性的细胞生长支架的制备方法 |
KR101982760B1 (ko) * | 2017-06-13 | 2019-05-28 | 한국과학기술연구원 | 초임계 유체-유기용매 시스템을 이용한 탈세포화 조직 기반의 하이드로겔의 제조방법 |
KR102014248B1 (ko) * | 2017-07-12 | 2019-08-26 | 순천향대학교 산학협력단 | 이상 인산 칼슘이 탑재된 탈세포화된 돼지 피부 유래 주입형 세포외 기질 기반 하이드로겔의 제조방법 |
WO2019211874A2 (en) * | 2018-05-02 | 2019-11-07 | Pandorum Technologies Private Limited | A liquid cornea hydrogel composition |
WO2019211873A2 (en) * | 2018-05-02 | 2019-11-07 | Pandorum Technologies Private Limited | A liquid cornea composition |
KR102256858B1 (ko) | 2020-03-02 | 2021-05-27 | 포항공과대학교 산학협력단 | 신장조직의 탈세포화 방법, 이를 통하여 생성된 탈세포화 물질 및 이를 포함하는 바이오 잉크 |
CN112516371A (zh) * | 2020-12-23 | 2021-03-19 | 医工瑞思(福建)工程研究中心有限公司 | 一种组织特异性伤口敷料及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005120597A1 (en) * | 2004-06-10 | 2005-12-22 | Woo Sam Park | Injectable filler made by acellular dermis |
US20100209408A1 (en) * | 2001-10-18 | 2010-08-19 | Lifecell Corporation | Remodeling of Tissues and Organs |
WO2012027514A2 (en) * | 2010-08-24 | 2012-03-01 | The Regents Of The University Of California | Compositions and methods for cardiac therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH092397A (ja) | 1995-06-23 | 1997-01-07 | Shimadzu Corp | 射出座席装置 |
DE69941216D1 (de) | 1998-06-19 | 2009-09-17 | Lifecell Corp | Teilchenförmige zellfreie gewebematrix |
US20050019404A1 (en) * | 2003-06-30 | 2005-01-27 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
JP4092397B2 (ja) | 2002-09-10 | 2008-05-28 | 国立循環器病センター総長 | 超高静水圧印加による移植用生体組織の処理方法 |
AU2003284159A1 (en) * | 2002-10-23 | 2004-05-13 | The Research Foundation Of State University Of Newyork | Fibrin-based tissue-engineered vasculature |
JP4189484B2 (ja) | 2002-12-12 | 2008-12-03 | 国立循環器病センター総長 | マイクロ波照射による生体組織の処理方法 |
JP2008111530A (ja) | 2006-10-31 | 2008-05-15 | Sankei Giken:Kk | 管継手 |
WO2008111530A1 (ja) | 2007-03-09 | 2008-09-18 | National University Corporation, Tokyo Medical And Dental University | 脱細胞化軟組織の調製方法、移植片、及び培養部材 |
JP2009050297A (ja) | 2007-08-23 | 2009-03-12 | Tokyo Medical & Dental Univ | 脱細胞処理液、脱細胞化組織の調製方法、移植片、及び培養部材 |
WO2009081408A2 (en) * | 2007-12-26 | 2009-07-02 | Metamorefix | Pulverized fibrin clots and pharmaceutical compositions containing them |
KR101056069B1 (ko) * | 2008-10-13 | 2011-08-10 | 아주대학교산학협력단 | 동물조직 분말을 이용한 다공성 3차원 지지체의 제조방법 |
JP5526573B2 (ja) | 2009-03-26 | 2014-06-18 | 国立大学法人 東京医科歯科大学 | 脱細胞化生体組織の調製方法 |
JP2013042677A (ja) | 2011-08-22 | 2013-03-04 | Tokyo Medical & Dental Univ | 脱細胞処理液、脱細胞化角膜の調製方法、及び脱細胞化角膜を備える移植片 |
CA2894145C (en) * | 2013-01-08 | 2020-01-07 | The Chemo-Sero-Therapeutic Research Institute | Artificial blood vessel using decellularized blood vessel sheet |
EP3556406B1 (en) * | 2013-05-07 | 2021-12-22 | National University Corporation Tokyo Medical and Dental University | Method for producing particulate decellularized tissue |
-
2014
- 2014-05-02 KR KR1020157033527A patent/KR102339700B1/ko active IP Right Grant
- 2014-05-02 EP EP14795291.5A patent/EP2995326B1/en active Active
- 2014-05-02 CN CN201480038295.XA patent/CN105658250B/zh active Active
- 2014-05-02 JP JP2015515916A patent/JP6553507B2/ja active Active
- 2014-05-02 CA CA2911592A patent/CA2911592C/en active Active
- 2014-05-02 WO PCT/JP2014/062544 patent/WO2014181886A1/ja active Application Filing
- 2014-05-02 US US14/888,871 patent/US20160051731A1/en active Pending
-
2016
- 2016-09-01 HK HK16110377.4A patent/HK1222137A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100209408A1 (en) * | 2001-10-18 | 2010-08-19 | Lifecell Corporation | Remodeling of Tissues and Organs |
WO2005120597A1 (en) * | 2004-06-10 | 2005-12-22 | Woo Sam Park | Injectable filler made by acellular dermis |
WO2012027514A2 (en) * | 2010-08-24 | 2012-03-01 | The Regents Of The University Of California | Compositions and methods for cardiac therapy |
Non-Patent Citations (3)
Title |
---|
JENNIFER M. SINGELYN等: ""Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering"", 《BIOMATERIALS》 * |
LIN, PB等: ""A Study on Repair of Porcine Articular Cartilage Defects With Tissue-Engineered Cartilage Constructed In Vivo By Composite Scaffold Materials"", 《ANNALS OF PLASTIC SURGERY》 * |
MATTHEW T. WOLF等: ""A hydrogel derived from decellularized dermal extracellular matrix"", 《BIOMATERIALS》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019100454A1 (zh) * | 2017-11-27 | 2019-05-31 | 大连理工大学 | 一种三维肿瘤模型脱细胞多孔支架、构建方法及其应用 |
CN108295311A (zh) * | 2018-03-07 | 2018-07-20 | 南京市第医院 | 一种温敏型肾脏细胞外基质水凝胶的制备方法 |
CN109890121A (zh) * | 2019-04-01 | 2019-06-14 | 西安交通大学 | 一种等离子体发生装置及等离子体凝胶制备方法 |
CN110038163A (zh) * | 2019-04-16 | 2019-07-23 | 上海大学 | 一种用于修复腹壁缺损的水凝胶复合生物补片制备方法 |
CN110038163B (zh) * | 2019-04-16 | 2021-11-05 | 上海大学 | 一种用于修复腹壁缺损的水凝胶复合生物补片制备方法 |
CN110638684A (zh) * | 2019-09-02 | 2020-01-03 | 深圳兰度生物材料有限公司 | 一种可注射的胶原组合物及制备方法 |
CN114099782A (zh) * | 2021-12-02 | 2022-03-01 | 龚玉兰 | 一种可重构的子宫衍生材料的制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2014181886A1 (ja) | 2017-02-23 |
EP2995326A4 (en) | 2017-01-11 |
EP2995326B1 (en) | 2019-07-24 |
EP2995326A1 (en) | 2016-03-16 |
HK1222137A1 (zh) | 2017-06-23 |
CN105658250B (zh) | 2019-02-26 |
JP6553507B2 (ja) | 2019-07-31 |
KR102339700B1 (ko) | 2021-12-14 |
WO2014181886A1 (ja) | 2014-11-13 |
KR20160025502A (ko) | 2016-03-08 |
CA2911592A1 (en) | 2014-11-13 |
US20160051731A1 (en) | 2016-02-25 |
CA2911592C (en) | 2021-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105658250A (zh) | 包含颗粒状脱细胞组织的混合凝胶 | |
US20180125897A1 (en) | Decellularized Adipose Cell Growth Scaffold | |
Tremblay et al. | Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice | |
AU2018226406B2 (en) | Tissue graft | |
CN107224617B (zh) | 一种以脾脏细胞外基质为原料的水凝胶及其制备方法 | |
CN104055795B (zh) | 一种可注射植入剂及其制备方法 | |
CN105246495A (zh) | 来自非哺乳动物组织的脱细胞化的生物材料 | |
TW200927074A (en) | Colloidal frame used in tissue engineering | |
DE68918922T3 (de) | Biologische Unterlage für Zellkulturen, bestehend aus durch Thrombin koagulierte Plasmaproteine, ihre Verwendung für die Keratinozytenkultur, deren Rückgewinnung und Transport für therapeutische Verwendungszwecke. | |
KR20120089235A (ko) | 저산소 조건 하에 배양된 세포로부터의 조정 배지 및 세포외 기질 조성물 | |
CN103705542A (zh) | 一种脱细胞血管基质凝胶及其制备方法和应用 | |
KR102597594B1 (ko) | 오가노이드의 생체 이식용 조성물 | |
CN105358188A (zh) | 用离体扩增的脂肪组织源性干细胞进行脂肪植入来实现整容性乳房填充或面部填充和/或年轻化 | |
JP2022501118A (ja) | 脂肪由来幹細胞およびゼラチンを含む生体材料ならびにその製造方法 | |
CN114410583B (zh) | 一种基于动物脂肪组织来源水凝胶的神经/血管网络及其构建方法和应用 | |
CN107250348A (zh) | 使用表达lgr4、lgr5和lgr6的上皮干细胞在组织应用中开发和使用最小极性化功能细胞微聚集体单元的方法 | |
RU2570034C1 (ru) | Способ наращивания объема костной ткани в зонах дефекта альвеолярного отростка челюсти | |
RU2526814C1 (ru) | Способ восстановления кожного покрова у пациентов с обширными ранами с дефектом мягких тканей (варианты) | |
Ghiringhelli et al. | Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues | |
CN106999554A (zh) | 生物胶及其作为药物的用途 | |
Früh | Adipose tissue-derived microvascular fragments: A novel prevascularization strategy in skin tissue engineering | |
TW202113069A (zh) | 包括脂肪幹細胞和明膠的生物材料和產生該生物材料之方法 | |
Biedermann et al. | In vivo efficacy proof of concept of a large-size bioprinted dermo-epidermal substitute for permanent wound coverage | |
RU2597085C2 (ru) | Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты) | |
CN117551604A (zh) | 搭载子宫内膜间充质干细胞及上皮类器官的脱细胞羊膜支架复合体修复子宫内膜损伤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1222137 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200309 Address after: Kumamoto, Japan Co-patentee after: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL University Patentee after: THE CHEMO-SERO-THERAPEUTIC Research Institute Co-patentee after: SAPPORO MEDICAL University Co-patentee after: ADEKA Corp. Address before: Xiongben County, Xiongben, Japan Co-patentee before: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL University Patentee before: THE CHEMO-SERO-THERAPEUTIC Research Institute Co-patentee before: SAPPORO MEDICAL University Co-patentee before: ADEKA Corp. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231110 Address after: Tokyo, Japan Patentee after: ADEKA Corp. Patentee after: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL University Patentee after: SAPPORO MEDICAL University Address before: Kumamoto, Japan Patentee before: THE CHEMO-SERO-THERAPEUTIC Research Institute Patentee before: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL University Patentee before: SAPPORO MEDICAL University Patentee before: ADEKA Corp. |